Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Stromelysin inhibitors: New approach to treating arthritis?

Aug. 29, 1997

Familial Mediterranean fever gene discovered

Aug. 28, 1997

MMP inhibitors effective in rat model of arthritis

Aug. 26, 1997

Antiinflammatory selectin-binding peptides from Affymax

Aug. 25, 1997

Indomethacin prodrug with potent antiinflammatory effects, low ulcerogenicity

Aug. 25, 1997

New COX-2 inhibitor series reported by Searle

Aug. 22, 1997

Celgene receives patent for SelCID

Aug. 21, 1997

Boston Life Sciences completes phase III trial of Therafectin

Aug. 20, 1997

Salagen approved for Sjogren's syndrome in Canada

Aug. 20, 1997

New treatment for osteoarthritis approved for marketing in U.S.

Aug. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...